This study aims to evaluate the feasibility, acceptability, and effectiveness of dispensing
mifepristone via a mail-order pharmacy. The investigators will recruit patients at up to 10
primary care and internal medicines sites not currently providing abortion services around
the country, as well as abortion clinic sites. Patients will go through routine in clinic
visits to determine eligibility and then will receive the medications in the mail at their
preferred address. The investigators will survey patients 3 and 14 days after the initial
clinic visit and interview providers at the end of the study.